Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus

Diabetes/metabolism Research and Reviews
Nancy Samir Elbarbary

Abstract

Severe hypoglycaemia during the daytime of Ramadan fasting is a highly feared complication. In a prospective study, we investigated the effect of the low-glucose suspend (LGS) algorithm on the frequency of hypoglycaemia in adolescents with T1DM who wished to fast during Ramadan. Sixty patients (19 males and 41 females, 15.6 ± 2.7 years, duration of diabetes 5.8 ± 2.9 years, pump therapy for 1.73 ± 0.99 years, used the Paradigm(®) Veo(™) System (Medtronic) and were divided into two groups: first (n=25), those who used the sensor with low-glucose suspend (LGS) feature and second (n = 35), those who used the sensor but turned off low-glucose suspend (LGS) feature. A total of 2716 LGS alerts occurred, and 48.6% began in the afternoon between 4pm and 7pm. The mean duration of LGS events was 26.5 min, 38% lasted for <5 min and 5.3% lasted for 120 min. Among these episodes, the mean sensor glucose was 62.3 ± 5.96 mg/dL at LGS activation, rose to 129.8 ± 11.6 mg/dL by the end of the LGS episode (when insulin delivery was automatically resumed) and was 155.6 ± 11.1 mg/dL at 240 min. LGS usage significantly reduced area under the curve (AUC) <70, AUC <60 mg/dL (p = 0.0001) and >240 mg/dL (p = 0.006). None of the LGS-on group broke their ...Continue Reading

References

Aug 27, 2005·Diabetes Care·Monira Al-AroujKhaled Al-Rubean
Dec 24, 2005·Journal of Endocrinological Investigation·H S KassemS T Azar
May 2, 2006·Diabetes Research and Clinical Practice·B BenajiH El Ghomari
Oct 24, 2009·Diabetes Technology & Therapeutics·Bruce BuckinghamH Peter Chase
Jan 20, 2010·Diabetes Technology & Therapeutics·Daniela ElleriRoman Hovorka
Mar 10, 2010·Diabetes Technology & Therapeutics·Mahmoud M BenbarkaSamar Abu Awad
Jun 12, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·V BravisD Devendra
Jul 30, 2010·Diabetes Care·Monira Al-AroujAbraham Thomas
Aug 11, 2011·Diabetes Technology & Therapeutics·Thomas DanneAndreas Thomas
Oct 27, 2011·Journal of Diabetes Science and Technology·Pratik AgrawalFrancine R Kaufman
Oct 27, 2011·Journal of Diabetes Science and Technology·Eda Cengiz
Feb 10, 2012·Diabetes Technology & Therapeutics·Satish GargFrancine R Kaufman
Jun 27, 2015·BMJ Open Diabetes Research & Care·Mahmoud IbrahimGuillermo E Umpierrez

❮ Previous
Next ❯

Citations

Oct 18, 2016·Diabetes Technology & Therapeutics·Alex ZhongFrancine R Kaufman
Jul 25, 2019·Diabetes Technology & Therapeutics·Stefan PleusGuido Freckmann
Sep 11, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Syed Haris Ahmed, Saira Gallo
Sep 11, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Syed H AhmedNazim Ghouri
Dec 16, 2020·Diabetes Research and Clinical Practice·Mohamed HassaneinNancy Samir Elbarbary
Sep 15, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Syed Haris Ahmed, Saira Gallo
Sep 15, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Syed H AhmedNazim Ghouri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.